Clinical Trial Detail


Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at :

NCT ID NCT04616248
Title Radio-immunotherapy (CDX-301, Radiotherapy, CDX-1140 and Poly-ICLC) for the Treatment of Unresectable or Metastatic Breast Cancer Patients
Recruitment Not yet recruiting
Gender both
Phase Phase I
Variant Requirements Yes
Sponsors Roswell Park Cancer Institute

breast cancer


CDX-1140 + CDX-301 + Poly ICLC

Age Groups: senior | adult
Covered Countries USA

Facility Status City State Zip Country Details
USC/Norris Comprehensive Cancer Center Los Angeles California 90033 United States Details
*Shaded cells indicate that there was no data available from for the field